TaiDoc TechnologyTPE:4736 -1.20%73 EBITDA Margin % is 45.97% as of Dec. 2025, which is 35% above its 10-year median of 34.16. GuruFocus rates TPE:4736 with a GF Score™ of 73/100 and a GF Value™ of NT$111.99 (Fairly Valued). The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, TaiDoc Technology ranks better than 97.92% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. TaiDoc Technology's EBITDA for the
three
months ended in Dec. 2025 was NT$473 Mil. TaiDoc Technology's Revenue for the
three
months ended in Dec. 2025 was NT$1,028 Mil. Therefore, TaiDoc Technology's EBITDA margin for the quarter that ended in Dec. 2025 was 45.97%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
TaiDoc Technology EBITDA Margin % Related Terms
TaiDoc Technology EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for TaiDoc Technology's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:4736 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, TaiDoc Technology's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TaiDoc Technology EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, TaiDoc Technology's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where TaiDoc Technology's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TaiDoc Technology (TPE:4736) has a EBITDA Margin % of 45.97% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on TaiDoc Technology and its competitors. This is 35% above median its historical median of 34.16. Over the past decade, TaiDoc Technology's EBITDA Margin % has ranged from 25.03 to 47.93. According to the industry distribution chart, TaiDoc Technology ranks #17 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 2.1%.
Is TaiDoc Technology's EBITDA Margin % too high?
TaiDoc Technology's current EBITDA Margin % of 45.97% is 35% above median its 10-year median of 34.16. Over the past 10 years, this metric has ranged from a low of 25.03 to a high of 47.93. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. TaiDoc Technology's value of 45.97% is 515% above this industry median. Based on the distribution chart, TaiDoc Technology ranks #17 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, TaiDoc Technology has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does TaiDoc Technology's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, TaiDoc Technology ranks #17 out of 816 companies for EBITDA Margin %. This places TaiDoc Technology in the top 2% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.48. TaiDoc Technology's value of 45.97% is 515% above this benchmark. Historically, TaiDoc Technology's own EBITDA Margin % has ranged from 25.03 to 47.93 over the past decade. While the company's 10-year median is 34.16 vs. the industry median of 7.48, TaiDoc Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TaiDoc Technology's current EBITDA Margin % of 45.97% is 515% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on TaiDoc Technology and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TaiDoc Technology's current EBITDA Margin % is 45.97%, which is 35% above median its own 10-year median of 34.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TaiDoc Technology stock overvalued right now?
Based on GuruFocus' analysis, TaiDoc Technology (TPE:4736) is currently considered Fairly Valued. The stock's GF Value™ is NT$111.99, compared to a current price of NT$123.00 — trading 9.8% above its estimated fair value. The current EBITDA Margin % is 45.97%, which is 35% above median its 10-year median of 34.16 and 515% above the Medical Devices & Instruments industry median of 7.48. TaiDoc Technology's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For TaiDoc Technology (TPE:4736), the current EBITDA Margin % is 45.97% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TaiDoc Technology (TPE:4736) Overvalued in 2026?
Based on GuruFocus' analysis, TaiDoc Technology stock appears to be overvalued.
The current stock price of NT$123.00 is trading 9.8% above its estimated GF Value™ of NT$111.99.
GuruFocus considers TaiDoc Technology to be Fairly Valued.
Key valuation signals for TPE:4736:
EBITDA Margin %: 45.97% (35% above median its 10-year median of 34.16)
GF Value™: NT$111.99 vs. price of NT$123.00 (9.8% above fair value)
Industry Position: 515% above the Medical Devices & Instruments median (#17 of 816)
No single metric tells the full story. See the TPE:4736 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TaiDoc Technology Corp is engaged in the research and development, manufacture, and sales of various electronics components and medical devices. Its products and services include In Vitro Diagnostic, Medical Device, and TeleHealth. It has three segments: Manufacturing of Medical Devices, Precision Finishing Division, and Sales of Medical Devices. It derives the majority of its revenue from the Manufacturing of Medical Devices. Geographically, the company derives its key revenue from Europe and the rest from the Americas, the Middle East, Asia, Taiwan, and others.
73GF Score
Get the complete analysis for TPE:4736
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4736 has been successfully added to your 
